Selected TACA Publications

Büll C, Stoel MA, den Brok MH, Adema GJ. Sialic acids sweeten a tumor's life. Cancer Res. 2014 Jun 15; 74(12); 3199-3204.

Christiansen MN, Chik J, Lee L, Anugraham M, Abrahams JL, Packer NH. Cell surface protein glycosylation in cancer. Proteomics. 2014 Mar; 14(4-5): 525-46.

Dall'Olio F, Malagolini N, Trinchera M, Chiricolo M. Sialosignaling: Sialyltransferases as engines of self-fueling loops in cancer progression. Biochim Biophys Acta. 2014 Jun 17; 1840(9): 2752-2764.

Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer. 2005 Jul; 5(7): 526-42.

Häuselmann I, Borsig L. Altered tumor-cell glycosylation promotes metastasis. Front Oncol. 2014 Feb 13; 4:28.

Rabu C, McIntosh R, Jurasova Z, Durrant L. Glycans as targets for therapeutic antitumor antibodies. Future Oncol. 2012 Aug; 8(8): 943-60.

TACAs & Immune Regulation

Crespo HJ, Lau JT, Videira PA. Dendritic cells: a spot on sialic acid. Front Immunol. 2013 Dec 27; 4:491.

Dalziel M, Crispin M, Scanlan CN, Zitzmann N, Dwek RA. Emerging principles for the therapeutic exploitation of glycosylation. Science. 2014 Jan 3; 343(6166): 1235681.

van Kooyk Y, Rabinovich GA. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat Immunol. 2008 Jun; 9(6): 593-601.